Back to top

NVCT Maintained by Roth Capital -- Price Target Raised to $33

NVCT Maintained by Roth Capital -- Price Target Raised to $33

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nuvectis Pharma, Inc. (NVCT)